Form 4: STERIS plc: Executive Reports Share Transaction

STERIS plc executive Mary Clare Fraser reports a transaction involving ordinary shares, with a portion withheld for tax obligations.

Summary

• Mary Clare Fraser, SVP & Chief HR Officer of STERIS plc, reported a transaction on June 1, 2026.
• 673 ordinary shares were withheld from a vesting of 2,313 restricted shares to cover applicable tax liabilities.
• The value of these withheld shares was based on the NYSE closing market price on June 1, 2026.
• Following this transaction, Fraser beneficially owns 12,209 ordinary shares directly.
• Additionally, 6,573 ordinary shares remain restricted, with restrictions lapsing on various dates through June 5, 2028.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction related to executive compensation and tax obligations, with no significant new financial information or strategic shifts.

Positives

• Vesting of restricted shares indicates continued employee incentive and retention programs.
• The withholding of shares for taxes is a standard and compliant practice, ensuring tax obligations are met.
• The executive continues to hold a significant number of shares, suggesting alignment with shareholder interests.

Negatives

• A portion of vested shares were withheld, reducing the immediate net shares received by the executive.
• The exact value of the withheld shares is not explicitly stated, only that it covers tax obligations.

Risks

• Future tax law changes could impact the value of shares withheld or the tax burden on executives.
• The remaining restricted shares are subject to vesting schedules, meaning their full benefit is not yet realized.

Future Outlook

The filing details the vesting of restricted shares and the lapse of restrictions on other shares over the next several years, indicating ongoing equity-based compensation plans.

Management Comments

• 673 shares were withheld from the 2,313 restricted shares that vested on June 1, 2026. These 673 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer.
• These vested shares were valued at the NYSE closing market price on June 1, 2026.
• As of June 1, 2026, 6,573 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,028 on June 2, 2026; 835 on June 3, 2026; 1,360 on June 4, 2026; 835 on June 3, 2027; 680 on June 4, 2027 and 835 on June 5, 2028.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing changes in beneficial ownership by insiders. This specific filing reflects standard executive compensation practices involving restricted stock awards and tax withholding.

Stakeholder Impact

• Shareholders: The transaction does not directly impact the total number of outstanding shares but reflects the company's compensation structure.
• Employees: The vesting and tax withholding process is a standard component of executive compensation.
• Management: Mary Clare Fraser's beneficial ownership remains substantial, aligning her interests with long-term company performance.

Next Steps

• Monitoring the lapse of restrictions on the remaining 6,573 ordinary shares through June 5, 2028.
• Observing future Form 4 filings for any further transactions by Mary Clare Fraser or other insiders.

Key Dates

Keywords

STERIS plc, STE, Form 4, Insider Transaction, Share Vesting, Restricted Stock, Tax Withholding, Beneficial Ownership, Mary Clare Fraser, Executive Compensation